NR4A1 and atherosclerosis: Understanding the GRK2/AP‐1/NR4A1 signaling axis in disturbed flow‐induced vascular endothelial dysfunction and atherosclerosis will aid in the development of novel drugs, offering more targeted and effective treatment options for vascular diseases.